DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gillmore R, Stuart S, Kirkwood A , et al.
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.
J Hepatol 2011;
55 (6) 1309-1316
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.